24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
BiomX
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
15:00
Doti AI raises $7M Seed round to help enterprises securely access and utilize internal data
15:00
Greylock appoints Mor Chen as partner to lead Israeli investments
14:41
Full list of Israeli high-tech funding rounds in 2025
14:38
Eleos doubles in value as it raises $60 million to disrupt behavioral healthcare
More stories
Buzz
Most popular
Daily
Weekly
1
Sam Altman-backed Apex Security in advanced talks to be acquired by Varonis for up to $40M
2
"Everyone will be a manager" - what the world of work will look like with AI agents
3
Facial recognition firm Oosto, formerly AnyVision, sold for $125M after raising $352M
4
What went wrong at AnyVision? Lessons from a $352M flameout
5
Mitiga raises $30M Series B to defend cloud services from cyberattacks
More news
BiomX
3 stories about BiomX
Biomed Company BiomX Merges With New York-Listed Chardan Healthcare
17.07.19
|
Meir Orbach
BiomX develops customized therapies for conditions such as acne and inflammatory bowel disease
Phage Therapies Company BiomX Raises $32 Million
20.02.19
|
Amarelle Wenkert
BiomX develops customized therapies based on bacteriophages—viruses that invade bacterial cells and can be used to treat infections
Phage Therapies Company BiomX Signs Johnson & Johnson Collaboration
13.12.18
|
Lilach Baumer
Bacteriophages are viruses that invade bacterial cells and can be used to treat bacterial infections. Phage therapy is often discussed as an alternative to traditional antibiotics
Please ensure Javascript is enabled for purposes of
website accessibility